Skip to main navigation Skip to search Skip to main content

Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma

  • Marissa L. Cann
  • , Laura E. Herring
  • , Lauren L. Haar
  • , Thomas S.K. Gilbert
  • , Dennis Goldfarb
  • , Kristy L. Richards
  • , Lee M. Graves
  • , David S. Lawrence

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Biochemistry, Genetics and Molecular Biology